Wire Stories

Moderna Confirms Supply Agreement with the Ministry of Health to Supply Singapore with mRNA Vaccine Against COVID-19 (mRNA-1273)

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new…

6 years ago

Accenture Helps Rakuten Mobile Launch Fully Virtualized Cloud-Native Mobile Network

New mobile network brings all the telecommunication provider’s operations to the cloud NEW YORK & TOKYO--(BUSINESS WIRE)--Accenture (NYSE: ACN) has…

6 years ago

OPENEDGES Signs Semiconductor Design IP License Agreement With Top-Tier Global Semiconductor Company

OPENEDGES is a leader in AI Semiconductor Design IP SEOUL--(BUSINESS WIRE)--OPENEDGES Technology, Inc., the world’s leading supplier of AI computing…

6 years ago

Shardul Amarchand Mangaldas & Co. Enables Work from Anywhere with Citrix®

Leading law firm uses digital workspace solutions to deliver consistent, secure and reliable experience that empowers employees to perform at…

6 years ago

Intercontinental Exchange Launches 10 New MSCI® Index Futures

Four New Contracts Help Manage Climate Risk and Are Only Available on ICE Futures U.S. The Additional Six Contracts Provide…

6 years ago

TROPION-Lung01 Head-to-Head Phase 3 Trial Initiated to Evaluate Datopotamab Deruxtecan Versus Docetaxel in Previously Treated Patients with Advanced or Metastatic NSCLC Without Actionable Genomic Alterations

TOKYO & MUNICH & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced the initiation…

6 years ago

TROPION-Lung05 Phase 2 Trial of Datopotamab Deruxtecan Initiated in Patients with Advanced or Metastatic NSCLC with Actionable Genomic Alterations

TOKYO & MUNICH & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced the initiation…

6 years ago

ADC Therapeutics and Overland Pharmaceuticals Announce Formation of Overland ADCT BioPharma to Develop and Commercialize Lonca and other ADCs for Hematologic and Solid Tumor Indications in Greater China and Singapore

- Hillhouse-backed Overland Pharmaceuticals to initially contribute $50 million to fund operations and development LAUSANNE, Switzerland & SHANGHAI & BOSTON--(BUSINESS…

6 years ago

Can-Fite Reports on Progress With Its Namodenoson NASH Program

Top NASH U.S. Key Opinion Leaders advise on the design of a Phase IIb protocol Manufacturing of Namodenoson for the…

6 years ago

Gravity Launches an Idle Casual RPG ‘Poring Merge’ for the First Time in Brazil

A new idle casual RPG that anyone can easily enjoy With pre-registration by over 300,000 users, it is expected to…

6 years ago